A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema

In brief

The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

Key facts

Study ID

NCT07037901

Run by

Inmagene LLC

People needed

405

Starts

2025-06-17

Expected to finish

2028-08-01

Last updated by the study team

2026-05-27

Who can join

Age: 18 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Inmagene Site 1 — Lancaster, California, United States (enrolling)
• Inmagene Site 23 — Los Angeles, California, United States (enrolling)
• Inmagene Site 19 — Ocala, Florida, United States (enrolling)
• Inmagene Site 4 — Tampa, Florida, United States (enrolling)
• Inmagene Site 2 — Rolling Meadows, Illinois, United States (enrolling)
• Inmagene Site 6 — Kew Gardens, New York, United States (enrolling)
• Inmagene Site 21 — New York, New York, United States (enrolling)
• Inmagene Site 11 — Woodbury, New York, United States (enrolling)
• Inmagene Site 20 — Charlotte, North Carolina, United States (enrolling)
• Inmagene Site 10 — Fargo, North Dakota, United States (enrolling)
• Inmagene Site 9 — Columbus, Ohio, United States (enrolling)
• Inmagene Site 5 — Mayfield Heights, Ohio, United States (enrolling)
• Inmagene Site 3 — Portland, Oregon, United States (enrolling)
• Inmagene Site 12 — Anderson, South Carolina, United States (enrolling)
• Inmagene Site 8 — Southlake, Texas, United States (enrolling)
• Inmagene Site 7 — Burien, Washington, United States (enrolling)
• Inmagene Site 15 — Surrey, British Columbia, Canada (enrolling)
• Inmagene Site 22 — Vancouver, British Columbia, Canada (enrolling)
• Inmagene Site 17 — Greater Sudbury, Ontario, Canada (enrolling)
• Inmagene Site 13 — Mississauga, Ontario, Canada (enrolling)
• Inmagene Site 18 — North Bay, Ontario, Canada (enrolling)
• Inmagene Site 14 — Montreal, Quebec, Canada (enrolling)
• Inmagene Site 16 — Saskatoon, Saskatchewan, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.